Hospira Sues FDA Over Generic Precedex Carve-Out Approval
Hospira Inc. hit the U.S. Food and Drug Administration with a suit on Monday contesting the agency's approval of generic versions of its blockbuster sedative Precedex, claiming the FDA violated its...To view the full article, register now.
Already a subscriber? Click here to view full article